Korean Market
OWNR
DongKookPharmaceuticalCo
★

Largest shareholder Gwon Gi-beom and related parties reduce stake by 1.03%p via open market sales... No impact on control but may dampen investor sentiment

 
PERI
DongKookPharmaceuticalCo
★

DongKook Pharmaceutical 2026 Q1: Steady Performance and Continued Dividend Policy